MARKET

TRIB

TRIB

Trinity Biotech
NASDAQ

Real-time Quotes | Nasdaq Last Sale

3.290
-0.030
-0.90%
Closed 16:00 05/05 EDT
OPEN
3.390
PREV CLOSE
3.320
HIGH
3.390
LOW
3.240
VOLUME
104.93K
TURNOVER
--
52 WEEK HIGH
6.82
52 WEEK LOW
1.210
MARKET CAP
68.77M
P/E (TTM)
-11.4395
1D
5D
1M
3M
1Y
5Y
Point of Care Diagnostics Market Report 2021-2031
New York, May 05, May 05, 2021 (GLOBE NEWSWIRE via COMTEX) -- New York, May 05, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report...
GlobeNewswire · 22h ago
Autoimmune Disease Diagnostics Market Size 2021 Analysis, Share And Trends, Market Growth And Segment Forecast To 2023
May 05, 2021 (The Expresswire) -- Autoimmune Disease Diagnostics Market 2021 report tells about the production process, raw materials and equipment...
The Express Wire · 1d ago
Lateral Flow Readers Market Size 2021 Global Trend, Top Manufacturers, Regions Analysis and Leading 20 Countries and Forecast by 2027
May 05, 2021 (The Expresswire) -- "Final Report will add the analysis of the impact of COVID-19 on this industry." The global “Lateral Flow Readers Market”...
The Express Wire · 1d ago
Global Lateral Flow POC Reader Market Size, Share, Value, and Competitive Landscape 2020
May 04, 2021 (Heraldkeepers) -- Global Lateral Flow POC Reader Market Overview:Global Lateral Flow POC Reader Market Report 2020 comes with the extensive...
Heraldkeepers · 2d ago
Point of Care Infectious Disease Market Size, Share, 2021 Global Industry Growth, Trends, Demands, Business Opportunities and Forecast to 2025
Japan, Japan, Tue, 04 May 2021 03:20:51 / Comserve Inc. / -- Competitive Analysis: Alere, Thermo Fisher Scientific Inc, F. Hoffmann-La Roche Ltd, Siemens...
Comserve · 2d ago
Overview Of Value Stocks In The Healthcare Sector
The Meaning Behind Value Stocks
Benzinga · 2d ago
Global Elisa Analyzers Market Size 2021: Worldwide COVID-19 Impact Analysis, Business Opportunities, Key Applications, Demands, Growth, Trends Analysis and Forecast to 2026
May 03, 2021 (The Expresswire) -- The Global “Elisa Analyzers Market” 2021 research report is a historical overview and in-depth study on the current and...
The Express Wire · 2d ago
Syphilis Rapid Test Kit Market Global Research and Clinical Survey Report 2021-2025
May 03, 2021 (Market Insight Reports) -- The Global Syphilis Rapid Test Kit Market Research Report Forecast 2021 - 2025 The Report begins with an overview of...
Market Insight Reports · 3d ago
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of TRIB. Analyze the recent business situations of Trinity Biotech through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 1 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average TRIB stock price target is 7.00 with a high estimate of 7.00 and a low estimate of 7.00.
EPS
Institutional Holdings
Institutions: 50
Institutional Holdings: 7.45M
% Owned: 35.63%
Shares Outstanding: 20.90M
TypeInstitutionsShares
Increased
6
427.05K
New
7
263.13K
Decreased
8
456.48K
Sold Out
5
598.06K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
-0.94%
Healthcare Equipment & Supplies
-0.58%
Key Executives
Chairman/Director
Ronan O'Caoimh
Chief Financial Officer/Secretary/IR Contact Officer
Kevin Tansley
Chief Operating Officer/Executive Director
Rory Nealon
Chief Scientific Officer/Vice President
Eric Brouwer
Executive Director
James Walsh
Non-Executive Director
Clinton Severson
Non-Executive Independent Director
Denis Burger
Non-Executive Independent Director
Peter Coyne
Non-Executive Independent Director
James Merselis
Declaration Date
Dividend Per Share
Ex-Div Date
--
Dividend USD 0.22
06/05/2015
--
Dividend USD 0.22
06/06/2014
05/31/2013
Dividend USD 0.2
06/06/2013
06/05/2012
Dividend USD 0.15
06/06/2012
--
Dividend USD 0.1
06/07/2011
About TRIB
Trinity Biotech plc (Trinity Biotech) develops, acquires, manufactures and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market. The Company's products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes, and disorders of the liver and intestine. It operates through two segments: the Americas and Rest of World. Its products are classified as POC, emergency medicine, clinical laboratory and blood bank screening. Its POC brands include Uni-Gold and Recombigen. Emergency medicine diagnostics refer to its acute care testing, STAT labs, pre/post-operative units, physician office labs and the central laboratory. Trinity Biotech supplies clinical laboratory market with reagent products and other products through its clinical chemistry business. Trinity Biotech's blood bank screening business unit manufactures products to screen donated blood for transfusion-transmissible infections.

Webull offers kinds of Trinity Biotech plc (ADR) stock information, including NASDAQ:TRIB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TRIB stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading TRIB stock methods without spending real money on the virtual paper trading platform.